about
Respiratory motion correction for PET oncology applications using affine transformation of list mode data.GATE: a simulation toolkit for PET and SPECT.[(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6).Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET.Motion correction using anatomical information in PET/CT and PET/MR hybrid imaging.A novel partial volume effects correction technique integrating deconvolution associated with denoising within an iterative PET image reconstruction.Respiratory and cardiac motion correction in dual gated PET/MR imaging.Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging.Local respiratory motion correction for PET/CT imaging: Application to lung cancer.Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies.Simplified Quantification Method for In Vivo SPECT Imaging of the Vesicular Acetylcholine Transporter with 123I-Iodobenzovesamicol.Progressive supranuclear palsy: in vivo SPECT imaging of presynaptic vesicular acetylcholine transporter with [123I]-iodobenzovesamicol.Validation of a Monte Carlo simulation of the Philips Allegro/GEMINI PET systems using GATE.Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.Generation of 4-dimensional CT images based on 4-dimensional PET-derived motion fields.List-mode-based reconstruction for respiratory motion correction in PET using non-rigid body transformations.Estimating the amount of FDG uptake in physiological tissues.Super-resolution in respiratory synchronized positron emission tomography.Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.Contrast enhancement in emission tomography by way of synergistic PET/CT image combination.SUVpeak Performance in Lung Cancer: Comparison to Average SUV from the 40 Hottest Voxels.A phantom-based method to standardize dose-calibrators for new β+-emitters.Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.Potential of [18F]-fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas.Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT.Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma.Correction of respiratory motion in dual gated cardiac imaging in PET/CTUse of the GATE Monte Carlo package for dosimetry applicationsImaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomographyLiver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship
P50
Q31087363-4020D056-1DC5-4FE3-B488-9A106EA8D389Q31130081-1CBDB65A-FF11-4CC5-B723-868F707B6AECQ37217139-EE4DF74B-BECF-4803-9155-6A6F7A5E12DDQ38594909-DEFE11B4-E602-483F-B6A7-D7BF1C5DE59CQ38635833-5AD8C4D9-AFF5-4FF0-8AF1-DFFE301ED5C9Q39043047-D2ADDFE7-C69F-4B9F-BA59-868F6921BC5BQ39179032-EB4A2866-FEA7-443E-967B-C41A9A65E620Q40204841-2B1D2AA8-53F2-4210-BB97-327F64888033Q40475307-02FD2CB5-3639-430B-BEAD-9C561D63A31AQ43112508-42942574-E557-4AD6-A0D1-22CEC08F739CQ47971543-42999F24-751D-4732-8A38-AD0344B9AE30Q48212503-B6CB9A51-4F0C-432B-BD71-C0E3E4B83EB4Q48362731-8F70301A-BCF6-42AB-A58C-6C1026095463Q48655713-D2AE4277-5122-47CF-AA9F-FAFD51624957Q48825231-59885EF2-3EA3-4F39-8794-4A7BCD7C63E9Q48909025-296F5CFB-C4B2-49C0-A720-932544E7FE5BQ48974703-1210B722-870C-4B29-8678-FD7C66283E10Q50922683-2482F8ED-6962-4998-9416-14CD5110199DQ51063429-0075975B-03EB-493B-8357-4837930616E6Q51519201-7FE202B9-064F-4A02-8CFF-6655648C4331Q51696197-34E14946-0649-4042-BBEE-B2CEBD7D5727Q51892419-B20C07A7-2ED7-45A7-95A3-ADE9471CE210Q52988649-0A4C7919-BE40-4D80-8083-2B3B5A872B5EQ53045075-9565BBF6-0E05-4A71-97D6-3D497445FF70Q53063872-24EE3E23-B7C9-43AF-A000-0BC44A7E692BQ53090157-C3FC08EE-04CB-4660-8985-3000461621CBQ53255902-AB20015B-14ED-40C0-AB51-D2B37E35BC01Q55462754-BB8AFF66-B3D4-48ED-8BFE-C0E8344C3448Q57623010-513E9EAC-1DB0-4D56-AC73-37FDAB00A892Q63972763-F837E43F-AD82-42FA-8273-E3E126321ED2Q84967508-4EAE291C-AB76-480F-9D78-74330A1ED41FQ85840575-301BB60B-8C30-473F-AD6B-1823E702C8A7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frederic Lamare
@ast
Frederic Lamare
@en
Frederic Lamare
@es
Frederic Lamare
@nl
Frederic Lamare
@sl
type
label
Frederic Lamare
@ast
Frederic Lamare
@en
Frederic Lamare
@es
Frederic Lamare
@nl
Frederic Lamare
@sl
prefLabel
Frederic Lamare
@ast
Frederic Lamare
@en
Frederic Lamare
@es
Frederic Lamare
@nl
Frederic Lamare
@sl
P106
P1153
8551430300
P21
P31
P496
0000-0003-1289-7655